Pages that link to "Q51909816"

The following pages link to Differences in blood pregnenolone and dehydroepiandrosterone levels between schizophrenia patients and healthy subjects. (Q51909816):

Displaying 17 items.

• Pregnenolone rescues schizophrenia-like behavior in dopamine transporter knockout mice (Q21133801) (← links)
• Pregnenolone sulfate normalizes schizophrenia-like behaviors in dopamine transporter knockout mice through the AKT/GSK3β pathway (Q30416840) (← links)
• Progesterone reduces hyperactivity of female and male dopamine transporter knockout mice (Q30455767) (← links)
• Simultaneous quantification of GABAergic 3alpha,5alpha/3alpha,5beta neuroactive steroids in human and rat serum. (Q33703907) (← links)
• Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). (Q37300547) (← links)
• Pregnenolone, dehydroepiandrosterone, and schizophrenia: alterations and clinical trials. (Q37673373) (← links)
• Dehydroepiandrosterone Attenuates Cocaine-Seeking Behaviour Independently of Corticosterone Fluctuations (Q47660190) (← links)
• Targeting the Immune System with Pharmacotherapy in Schizophrenia (Q47837511) (← links)
• Association between a common CYP17A1 haplotype and anxiety in female anorexia nervosa (Q48008409) (← links)
• Pregnenolone-progesterone-allopregnanolone pathway as a potential therapeutic target in first-episode antipsychotic-naïve patients with schizophrenia (Q50046796) (← links)
• Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia (Q50632749) (← links)
• Pregnenolone treatment reduces severity of negative symptoms in recent-onset schizophrenia: an 8-week, double-blind, randomized add-on two-center trial (Q50659255) (← links)
• The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases. (Q51750311) (← links)
• Neurosteroids in Schizophrenia: Pathogenic and Therapeutic Implications. (Q52641631) (← links)
• Central intracrine DHEA synthesis in ageing-related neuroinflammation and neurodegeneration: therapeutic potential? (Q57458436) (← links)
• Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor (Q58732614) (← links)
• Stress and drug abuse-related disorders: The promising therapeutic value of neurosteroids focus on pregnenolone-progesterone-allopregnanolone pathway (Q90124577) (← links)